当前位置:首页 > 股票大全 > 羚锐制药 600285 财务分析

羚锐制药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

羚锐制药(600285)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入909,046,867.73,311,472,606.542,506,780,833.451,700,662,495.56
营业总成本696,497,752.042,683,303,531.911,988,216,290.951,347,263,731.98
营业利润220,826,418.61656,307,235.4539,096,882.96365,485,150.62
利润总额220,820,151.71653,044,169.92537,876,813.86364,453,362.63
净利润190,328,634.98568,115,699.33466,185,949.16317,027,264.79
其他综合收益-49,434,571.49-25,632,363.72,874,703.27-155,901.03
综合收益总额140,894,063.49542,483,335.63469,060,652.43316,871,363.76
羚锐制药(600285)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,949,498,793.692,598,932,741.622,446,358,773.912,390,808,530.83
非流动资产合计2,032,055,523.282,172,984,631.772,185,719,398.221,955,062,547.24
资产总计4,981,554,316.974,771,917,373.394,632,078,172.134,345,871,078.07
流动负债合计1,975,636,840.391,900,159,332.71,838,325,805.151,718,470,743.34
非流动负债合计64,227,765.7173,061,102.6975,014,459.6777,209,543.85
负债合计2,039,864,606.091,973,220,435.391,913,340,264.821,795,680,287.19
归属于母公司股东权益合计2,934,067,847.862,791,040,844.652,711,117,799.712,542,567,124.56
股东权益合计2,941,689,710.882,798,696,9382,718,737,907.312,550,190,790.88
负债和股东权益合计4,981,554,316.974,771,917,373.394,632,078,172.134,345,871,078.07
羚锐制药(600285)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计809,623,301.083,746,939,836.182,664,256,410.811,872,268,818.29
经营活动现金流出小计764,717,007.292,933,511,087.312,155,567,258.181,479,096,015.1
经营活动产生的现金流量净额44,906,293.79813,428,748.87508,689,152.63393,172,803.19
投资活动现金流入小计40,000,000524,332,662.54355,043,568.73300,190,543.31
投资活动现金流出小计97,440,536.53754,035,208.57541,176,405.91278,897,985.3
投资活动产生的现金流量净额-57,440,536.53-229,702,546.03-186,132,837.1821,292,558.01
筹资活动现金流入小计8,612,408.51102,844,440.2173,776,019.1969,605,797.01
筹资活动现金流出小计20,076,857.67375,578,367.85357,796,851.84357,121,697.79
筹资活动产生的现金流量净额-11,464,449.16-272,733,927.64-284,020,832.65-287,515,900.78
汇率变动对现金及现金等价物的影响694.05-2,374.145,851.1621,539.07
现金及现金等价物净增加额-23,997,997.85310,989,901.0638,541,333.96126,970,999.49
期末现金及现金等价物余额1,466,278,009.711,490,276,007.561,217,827,440.461,306,257,105.99
羚锐制药600285相关数据
今日股市大盘指数